Molecular mechanisms associated with multiple sclerosis progression, severity and phenotype
Peter Kosa, Keith Lumbard, Jing Wang, C. Jason Liang, Ruturaj Masvekar, Yujin Kim, Mihael Varosanec, Lori Jennings, Bibiana Bielekova
doi: https://doi.org/10.1101/2022.10.14.22281095
Peter Kosa
1Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA
Keith Lumbard
2Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research; Frederick, MD
Jing Wang
2Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research; Frederick, MD
C. Jason Liang
3Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA
Ruturaj Masvekar
1Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA
Yujin Kim
1Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA
Mihael Varosanec
1Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA
Lori Jennings
4Novartis Institutes for Biomedical Research; Cambridge, MA, USA
Bibiana Bielekova
1Neuroimmunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA
Posted October 17, 2022.
Molecular mechanisms associated with multiple sclerosis progression, severity and phenotype
Peter Kosa, Keith Lumbard, Jing Wang, C. Jason Liang, Ruturaj Masvekar, Yujin Kim, Mihael Varosanec, Lori Jennings, Bibiana Bielekova
medRxiv 2022.10.14.22281095; doi: https://doi.org/10.1101/2022.10.14.22281095
Molecular mechanisms associated with multiple sclerosis progression, severity and phenotype
Peter Kosa, Keith Lumbard, Jing Wang, C. Jason Liang, Ruturaj Masvekar, Yujin Kim, Mihael Varosanec, Lori Jennings, Bibiana Bielekova
medRxiv 2022.10.14.22281095; doi: https://doi.org/10.1101/2022.10.14.22281095
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11621)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3625)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2330)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6020)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)